Clofazimine as a drug for TB in the mouse model

Date:

January 29, 2015 at 12:15pm - 1:20pm

In this lecture, Dr. Jaques Grosset describes his effort to reproduce results of a multi-drug TB treatment regimen that utilized Clofazimine for treating patients with drug resistance, using the mouse model.

Video/Audio/Slides

Audio-only/Slides

Projects

Scale-up and implementation of TB diagnostics...

We are evaluating the implementation, cost-effectiveness, and potential epidemiological impact of scaling up Xpert across 19...

Read More

A randomized trial of preventive therapy for...

We are evaluating the efficacy and cost-effectiveness of levofloxacin preventive therapy for adult contacts of MDR TB patients...

Read More

Assessing the social value of novel regimens...

We are collaborating with investigators from the Berman Bioethics Institute to develop novel techniques for economic evaluation...

Read More